logo
Select company
Select metric
$ -13.55MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
23
Sector
56
Industry
45
History
56
$ 3.18Close
$ 2.08 - $ 6.95 52-Week Range
Ticker Information

Ticker

VVOS

Company Name

VIVOS THERAPEUTICS INC

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

VIVOS THERAPEUTICS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

VVOS - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 773K$ -14.32M$ -13.55M
3/31/2025$ 612K$ -11.24M$ -10.63M
12/31/2024$ 581K$ -11.14M$ -10.55M
9/30/2024$ 586K$ -12.57M$ -11.98M
6/30/2024$ 589K$ -12.04M$ -11.46M
3/31/2024$ 592K$ -15.64M$ -15.05M
12/31/2023$ 621K$ -13.58M$ -12.96M
9/30/2023$ 258K$ -15.41M$ -15.15M
6/30/2023$ 429K$ -18.75M$ -18.32M
3/31/2023$ 803K$ -20.22M$ -19.41M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • VIVOS THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA stands at $ -9.87M.
  • Over the past 5 years, VIVOS THERAPEUTICS INC's average EBITDA has been $ -15.72M.
  • The median EBITDA for VIVOS THERAPEUTICS INC during this period was $ -15.05M
  • VIVOS THERAPEUTICS INC reached its highest EBITDA over the past 5 years at $ -9.87M.
  • The lowest EBITDA recorded by VIVOS THERAPEUTICS INC in the same timeframe $ -24.09M

VIVOS THERAPEUTICS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
NMTC : NEUROONE MEDICAL TECHNOLOGIES CORP $ -4.97MXLO : XILIO THERAPEUTICS INC $ -54.59MNEPH : NEPHROS INC $ 1.49MALUR : ALLURION TECHNOLOGIES INC $ -18.92MPOCI : PRECISION OPTICS CORPORATION INC $ -5.34MCOCH : ENVOY MEDICAL INC $ -19.26MNXGL : NEXGEL INC $ -2.29MBCAB : BIOATLA INC $ -58.76MXAIR : BEYOND AIR INC $ -35.84MCRIS : CURIS INC $ -37.53M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for VIVOS THERAPEUTICS INC is calculated as follows: EBIT [ $ -10.62M ] + DepAmor [ $ 751.23K ]
(=) EBITDA [ $ -9.87M ]

VVOS - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -24.09M

Minimum

Sep 30, 2022

$ -9.87M

Maximum

Dec 31, 2019

$ -15.72M

Average

$ -15.05M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.87M with a standard deviation of $ 166.99M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -493.3M
max$ 590.6M
average$ 58.87M
median$ 8.87M
std$ 166.99M